已收盤 05-08 16:00:00 美东时间
+2.060
+2.61%
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
Citigroup analyst Patrick Cunningham maintains Corteva (NYSE:CTVA) with a Neutral and raises the price target from $83 to $85.
05-08 05:38
There’s a lot to be optimistic about in the Materials sector as 2 analysts just...
05-07 20:23
华盛资讯5月7日讯,Corteva Inc公布2026财年Q1业绩,公司Q1营收49.05亿美元,同比增长11.0%,归母净利润7.20亿美元,同比增长10.4%。
05-07 08:17
华盛资讯5月6日讯,Corteva Inc公布2026财年Q1业绩,公司Q1营收49.05亿美元,同比增长11.0%,归母净利润7.20亿美元,同比增长10.4%。
05-06 07:13
Corteva (NYSE:CTVA) affirms FY2026 Adj EPS guidance from $3.45-$3.70 to $3.45-$3.70 vs $3.65 analyst estimate..
05-06 04:34
Corteva (NYSE:CTVA) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $1.01 by 5.94 percent. This is a 5.31 percent decrease over earnings of $1.13 per share from the same period
05-06 04:33
First quarter sales reflect strength of Seed and Crop Protection technology portfolios and progress on growth platforms Continued productivity and cost initiatives across both businesses fur...
05-06 04:30
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Corteva names planned seed and genetics spin-off Vylor May 4 (Reuters) - U.S. agriscience company Corteva CTVA.N on Monday said it is naming the advanced seed and genetics unit it plans to spin off Vylor, replacing the placeholder name "SpinCo". The spin-off , announced last year, will carve out Cor
05-04 19:53